SCHEMBL29381334

SCHEMBL29381334

CC(C)(C)[Si](C)(C)OCCc1c(F)ccc(Cl)c1F

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ DUT P33316 2/20 0.32
▸ MPO P05164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21356206 1.00 DUT (0.32) DUTMPO
SCHEMBL21355872 0.86 DUT (0.31) DUT
SCHEMBL17398622 0.78 DUT (0.32) DUT
SCHEMBL20160917 0.77 GPR84 (0.35) DUT
SCHEMBL23409589 0.76 — —
SCHEMBL31691600 0.74 KDM4E (0.34) DUT
SCHEMBL26772128 0.74 APLNR (0.33) —
SCHEMBL9031600 0.74 — —
SCHEMBL19208399 0.71 DUT (0.36) DUTMPO
SCHEMBL20898062 0.71 CA12 (0.34) DUT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3765461-B1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) PRELUDE THERAPEUTICS INC (US) 2023-08-30 — — EP disclosed
EP-3946352-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 Prelude Therapeutics, Incorporated (US) 2022-02-09 — — EP disclosed
Send feedback